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 26 
Abstract  27 
Objectives To describe the features and diagnoses of a population of cats referred with 28 
pyrexia. Other aims were to report, and evaluate the utility of, clinical investigations 29 
performed, and describe any effect of treatment before referral on temperature at 30 
presentation and ability to make a diagnosis. 31 
 32 
Methods Clinical records of cats with pyrexia (≥39.2°C) documented at least twice were 33 
retrospectively reviewed. Cases were assigned into disease categories (infectious, 34 
inflammatory, immune-mediated, neoplastic, miscellaneous and no diagnosis [pyrexia of 35 
unknown origin, PUO]) based on diagnosis. The overall value of clinical investigations was 36 
assessed by classifying them as ‘enabling’, ‘assisting’ or ‘no assistance’ in achieving each 37 
diagnosis. The effect of treatment before referral was assessed for any association with 38 
temperature at presentation and ability to make a diagnosis (PUO versus other disease 39 
categories).  40 
 41 
Results 106 cases were identified. The most common cause of pyrexia was feline infectious 42 
peritonitis (22 cats, 20.8%) and the largest disease category was infectious (41/106, 38.7%). 43 
Inflammatory conditions were found in 19 (17.9%), neoplasia in 13 (12.3%), miscellaneous 44 
causes in 11 (10.4%) and immune-mediated disease in six (5.7%) cats. No diagnosis was 45 
reached in 16 (15.0%) cats, often despite extensive diagnostic investigations. Cytology and 46 
histopathology most often ‘enabled’ or ‘assisted’ in obtaining a diagnosis. Most cats (91 cats, 47 
85.8%) received treatment before referral, with antimicrobial treatment given to eighty-48 
  
seven (82.1%) cats. Prior treatment before referral was not associated with temperature at 49 
presentation nor with success in establishing a diagnosis.  50 
 51 
Conclusions and relevance This is the first study investigating causes of pyrexia in cats. 52 
Infectious diseases were most common and immune-mediated diseases were comparatively 53 
rare. 54 
 55 
56 
  
Introduction 57 
 Pyrexia (fever) is an increased body temperature secondary to the release of 58 
pyrogens and a raised thermoregulatory set point in the anterior hypothalamus1. It is part 59 
of the non-specific adaptive response of the body to disease and is thought to confer a 60 
significant evolutionary advantage. However, there are disadvantages of pyrexia and these 61 
tend to outweigh benefits when pyrexia becomes more severe or prolonged1. Pyrexia that 62 
remains undiagnosed despite investigations is referred to as pyrexia of unknown origin 63 
(PUO). Over 200 diseases have been associated with PUO in humans2. Precise definitions of 64 
PUO vary; extrapolating from human medicine, PUO in dogs and cats has been defined as 65 
a temperature of ≥39.2°C (102.5°F) of at least three weeks duration in which no obvious 66 
cause is found following at least three visits to the veterinary surgeon and/or three days of 67 
hospitalisation (including basic evaluation of history, clinical signs, physical examination 68 
and diagnostic testing [complete blood count, serum biochemistry, urinalysis])1. 69 
Recommendations regarding the diagnostic approach to pyrexia have been described in 70 
cats1, 3, 4, but as no studies investigating causes of pyrexia have been published in cats, such 71 
recommendations are experience-based rather than evidence-based. It has been stated that 72 
infectious causes are the most common reason for feline pyrexia3, 5 but no published 73 
evidence exists. Immune-mediated disease is known to be the most common cause of 74 
pyrexia in dogs6-8. 75 
 The aims of the present study were to describe the population characteristics of cats 76 
with pyrexia referred to two veterinary referral centres and to identify the causes of pyrexia. 77 
Further objectives were to report the clinical investigations performed and evaluate their 78 
  
usefulness in obtaining a diagnosis, and to describe treatments given before referral and 79 
their possible effect on temperature at presentation and ability to reach a diagnosis.  80 
  
Methods 81 
 The clinical databases of feline patients referred to the Small Animal Hospital, 82 
University of Bristol and the Small Animal Hospital, University of Glasgow January 2011-83 
June 2015 were retrospectively searched to identify cats with pyrexia. Databases and 84 
clinician case logs were searched using the terms ‘pyrexia’, ‘pyrexic’, ‘PUO’ and ‘fever’. Case 85 
records were then retrospectively reviewed (SS) and appropriate details entered into a 86 
spreadsheet (Excel for Windows, Microsoft). Details regarding signalment, history, physical 87 
examination and minimum database were obtained in all cats. Peak temperature 88 
documented by the referring veterinarian within the past month and temperature at 89 
presentation to the referral centre were recorded. Further diagnostic investigations were 90 
performed depending on clinical presentation and the attending clinician’s discretion. To 91 
be included pyrexia (rectal temperature ≥39.2°C ([102.56°F]) had to have been documented 92 
at least twice (to reduce the risk of cats with stress hyperthermia being included), including 93 
at least once at the referring veterinary practice. Cases were excluded if records were 94 
inadequate. 95 
 The study was approved by the University of Bristol’s Animal Welfare and Ethical 96 
Review Body (veterinary investigation number [VIN] 16/019) and the University of 97 
Glasgow’s Research Ethics Committee (37a/16). 98 
 99 
Treatment before referral 100 
 Any drug administered by the referring practice after the initial documentation of 101 
pyrexia was recorded. As this included a large range of drugs, individual agents were 102 
grouped into therapeutic classes: non-steroidal anti-inflammatory drugs (NSAIDs), 103 
  
antimicrobials, corticosteroids, opioid analgesics, ‘supportive’ gastrointestinal medications 104 
(e.g, antiemetics, antacids), and miscellaneous drugs.  105 
 106 
Diagnostic investigations 107 
 Investigations performed by the referring veterinarian and at the referral centre were 108 
recorded. For the purpose of analysis, neutrophilia was graded as mild (12 to <20 x 109/l), 109 
moderate (20 to <30 x 109/l) or severe (≥30 x 109/l); neutropenia was defined as <4 x 109/L. 110 
Anaemia was classified as mild (PCV 20 to ≤24%), moderate (15 to <20%), or severe (<15%). 111 
Increases in alanine aminotransferase (ALT) were graded as mild (<2 times upper reference 112 
range), moderate (≥2 to 3 times), or severe (>3 times). Hypoalbuminaemia was classified as 113 
mild (20 to <24 g/l), moderate (16 to <20 g/l), or severe (<16 g/l).  114 
 Imaging techniques included ultrasonography, radiography, CT, MRI and 115 
endoscopy. Cytological examination was performed on fine needle aspirates from any 116 
abnormal masses or enlarged lymph nodes. Feline immunodeficiency virus (FIV) antibody 117 
and feline leukaemia virus (FeLV) antigen testing was initially performed using Petchek 118 
ELISA (IDEXX) or FeLV/FIV SNAP (IDEXX), with polymerase chain reaction (PCR) testing 119 
and/or virus isolation performed if results were positive.  120 
 Each diagnostic investigation was retrospectively categorised as: ‘enabled’ a 121 
diagnosis, ‘assisted’ a diagnosis, or of ‘no assistance’7. In cases where a negative result 122 
contributed to a diagnosis, the test was reported as ‘assisted’ a diagnosis. A complete blood 123 
count and serum biochemistry were performed in all cats, their usefulness in obtaining a 124 
diagnosis was not examined.  125 
  
  126 
Cause of pyrexia: disease groups 127 
 Cats were retrospectively assigned into one of the following disease groups based on 128 
final diagnosis: infectious, inflammatory, immune-mediated, neoplasia, miscellaneous and 129 
no diagnosis reached (PUO). Where more than one disease process from different categories 130 
was diagnosed, the disease attributed to be the cause of the pyrexia was classified. When 131 
this was unclear, cases were defined as miscellaneous.  132 
 133 
Outcome 134 
 Whether cats survived to discharge, were euthanased or died was recorded.  135 
 136 
Statistical analysis  137 
 Statistical analysis was performed using SPSS for Windows v23 (IBM Corp). 138 
Descriptive statistics were prepared for all evaluated variables. Kolmogorov-Smirnov tests 139 
were used to test for normality; continuous variables were reported as means and standard 140 
deviations (sd) if normally distributed, and as medians and ranges if not normally 141 
distributed.  142 
Overall treatment before referral (yes/no) was assessed for association with 143 
temperature at presentation using a T-test. Treatment was assessed for association with 144 
success in making a diagnosis (i.e, PUO [no diagnosis] vs all other disease categories 145 
[diagnosis reached]) using χ2 test. Significance was defined as P<0.05.  146 
  147 
  
Results 148 
One hundred and six cats met the inclusion criteria. 149 
 150 
Signalment  151 
Of the 106 cats, the most common breed was domestic (69 [65.1%]; 64 [60.4%] 152 
domestic shorthair, five [4.7%] domestic longhair); the remaining 37 (34.9%) cats were 153 
pedigrees. These comprised seven (6.6%) Ragdolls, six (5.7%) Bengals, six (5.7%) British 154 
shorthairs, five (4.7%) Birmans, four (3.8%) Maine coons, three (2.8%) Siamese, and one each 155 
(0.9%) of Balinese, Devon Rex, Korat, Oriental, Persian and Russian Blue.  Median age was 156 
4.0 years (10 weeks–15 years).  157 
 158 
History and treatment before referral  159 
Diagnosis was known or suspected at the time of referral in 11 (10.3%) cats; these 160 
tended to be infectious (e.g, pyothorax, pyelonephritis, cellulitis), lymphoma (2 cats), or 161 
structural disease (e.g, ureteral obstruction, intestinal intussusception). Regarding cats with 162 
feline infectious peritonitis (FIP), two of 22 referring veterinarians mentioned FIP as a 163 
possible diagnosis at referral. Ninety-one cats (87.5%) received treatment before referral; 164 
treatment data were unavailable for two cases. Treatment had been given within 24-hours 165 
of referral in 77 (74.0%) cats. Antimicrobials were administered in 87 cats (83.7%) (Table 1); 166 
of these, 54 received one antimicrobial, 28 received antimicrobials from two different 167 
classes, and five from three different classes. Almost two-thirds of cats received NSAIDs 168 
(67/104, 64.4%) and approximately one-quarter received corticosteroids (25/104, 24.0%). 169 
Opioid analgesia was administered to 30 cats (28.8%), 26 cats (25.0%) received 170 
  
gastrointestinal support medication, and 20 cats (19.2%) received other miscellaneous 171 
drugs.  172 
Mean (+sd) peak temperature documented before referral was 40.1°C (+0.5°C). 173 
Pyrexia was reported to be present for a median of four days (1-168 days) before 174 
presentation. Eighty one cats (76.4%) were pyrexic at referral and mean temperature at 175 
presentation was 39.7°C (+0.6°C). Overall treatment before referral was not associated with 176 
temperature at presentation (P=0.543), nor with success in reaching a diagnosis (P=0.999). 177 
As pyrexia associated with FIP is expected to be refractory to treatment, the association of 178 
treatment before referral was also assessed in non-FIP cats only, and no significant 179 
association was found (unpublished data). 180 
 181 
Diagnostic investigations 182 
The number of cats in which diagnostic investigations were performed and the 183 
usefulness of investigations in obtaining a diagnosis are shown in Table 2. Complete blood 184 
count and serum biochemistry were performed in all cats (results were unavailable in two 185 
cases). The most common abnormalities were neutrophil abnormalities and anaemia on 186 
complete blood count, and increased ALT and hypoalbuminaemia (Table 3) on serum 187 
biochemistry.  188 
 189 
Disease categories  190 
Final diagnoses and disease categories are listed in Table 4. Infectious disease 191 
represented the largest category (41/106, 38.7%). Within this category, FIP was diagnosed in 192 
  
22 cases. Inflammatory (non-infectious) disease comprised the second most common 193 
disease category (19/106, 17.9%) and neoplastic disease third (13/106, 12.3%). Pyrexia was 194 
attributable to miscellaneous conditions in 11 cats (10.4%). Immune-mediated disease was 195 
the smallest disease category (6/106, 5.7%). No diagnosis (PUO) was established in 16 cases 196 
(15.1%). The median ages of cats in each disease category are described in Table 5.  197 
 198 
Outcome  199 
Cats were hospitalised for a mean of 5.0 days (+3.2 days). Over two-thirds of cats 200 
(71/106, 67.0%) survived to discharge, 31 (29.2%) cats were euthanased and four (3.8%) died 201 
during hospitalisation.  202 
  203 
  
Discussion 204 
 This is this first published survey describing causes of pyrexia in referred cats. To the 205 
authors’ knowledge, there are no similar surveys of pyrexic cats in first opinion practice. 206 
Our study will therefore provide a useful comparison for future, ideally prospective, studies 207 
of pyrexic cats in both the first opinion, and referral, setting. Using the same grouping 208 
system previously described in a canine study7, we found infection to be the most common 209 
disease category. In contrast, immune-mediated disease was most commonly diagnosed in 210 
referral populations of pyrexic dogs6, 7. Infection is the most common cause for pyrexia in 211 
people2.  212 
  In terms of specific conditions, FIP was the most common diagnosis. Diagnosis was 213 
based on compatible clinicopathological findings and histopathology or positive feline 214 
coronavirus immunostaining9,10. Intermittent fever is one of the earliest signs of FIP9 and in 215 
one study body temperature exceeded 39.5°C in 81% of cats with FIP, and over 40°C in 216 
almost half of cases10. FIP remains a difficult disease to definitively diagnose, perhaps in 217 
part due to the fluctuating nature of pyrexia meaning fever and clinical signs may falsely 218 
appear to respond to antimicrobials, delaying investigation and/or diagnosis. The high 219 
prevalence of FIP in this population where so many cats had received antimicrobials 220 
(±NSAIDs) highlights the condition as the most common cause of pyrexia refractory to 221 
empirical treatment. It is important to note that the prevalence of FIP may be abnormally 222 
high as the participating institutions actively participate in FIP research, possibly resulting 223 
in a biased population; it has been suggested that differences in disease category prevalence 224 
in canine studies has been in part due to particular interests of the authors6, 11. 225 
  
 Apart from FIP, few other specific infections were diagnosed in this study, despite 226 
FIV/FeLV testing, Toxoplasma gondii serology and other infectious disease PCR tests being 227 
commonly performed. This likely reflects the low prevalence of specific infectious diseases 228 
in the UK, especially at referral level, although it may also reflect inappropriate test selection 229 
by the clinician. The poor overall diagnostic value of routine serological and immunological 230 
tests is well known in human medicine and there is debate over the minimal serological 231 
tests indicated in PUO patients, due to the low prevalence of implicated diseases2.  232 
 Inflammatory (non-infectious) conditions comprised the second most common 233 
disease category in pyrexic cats, and interestingly, were almost as common as infectious 234 
causes when FIP cases were not considered. The widespread use of antimicrobials in this 235 
population may have resulted in infectious causes being incorrectly classified as 236 
inflammatory (e.g, sterile versus non-sterile cellulitis, bacterial versus non-bacterial 237 
cholangiohepatitis). This is a limitation inherent in the retrospective nature of the study and 238 
may have resulted in an underestimation of infectious disease prevalence.   239 
 Neoplasia as a cause for pyrexia was seen in 12.3% cats, comparable to figures 240 
described in pyrexic dogs (9.5%6 and 7.6%7). Unsurprisingly, as the most common feline 241 
neoplasm, lymphoma was the most prevalent neoplasm in this study. Primary pulmonary 242 
tumours were the second most frequent, found in three cats, and have previously been 243 
reported to cause pyrexia11, likely because of their propensity to become necrotic due to 244 
their often large and solid nature.  245 
  
Immune-mediated disease appears to be a less common cause for pyrexia in cats than 246 
in dogs6-8, with only immune-mediated haemolytic anaemia and immune-mediated 247 
polyarthritis diagnosed in our population. 248 
Despite often extensive investigations, a definitive diagnosis was not reached in 15% 249 
of cases., comparable to canine studies6, 7. We hypothesise that cats with PUO had self-250 
limiting infections or transient inflammatory foci. In the present study, although most cats 251 
were referred without a known diagnosis (and often referred to as having PUO by the 252 
referring veterinarian), a cause was found in 85% of cases. The term ‘PUO’ should therefore 253 
be reserved for cases where extensive diagnostics have failed to identify the cause. Not all 254 
cases of PUO in this study met the definition proposed by Ramsey & Tasker (2017)1, as only 255 
four out of 16 cats had a duration of illness of more than three weeks. This is perhaps not 256 
surprising as investigations and treatment are likely to be instigated much earlier than three 257 
weeks in order to reduce patient morbidity.  258 
Due to the retrospective nature of the study and assessment of survival data to 259 
discharge only, it was not possible to assess if PUO was associated with outcome. Overall 260 
survival to discharge (67.0%) was comparable however to a high (70%) survival rate 261 
reported in dogs with miscellaneous causes for pyrexia6. The majority of humans with PUO 262 
will eventually spontaneously recover12.  263 
No association between treatment and success in reaching a diagnosis was found. 264 
Treatment before referral was not associated with temperature at presentation, in contrast 265 
to dogs where prior treatment reduced the prevalence of pyrexia at the time of referral7. 266 
This study also reported that the treatment of pyrexia was associated with a longer time to 267 
  
diagnosis7. Because of this, and the proposed protective benefit of pyrexia, it has been 268 
recommended to reserve antipyretic drugs for cases where body temperature exceeds 41°C 269 
or clinical signs attributable to fever are severe1.  270 
Broad-spectrum antimicrobials are widely recommended for all cases of unexplained 271 
pyrexia in dogs and cats1, 3, 11, and in keeping with this recommendation, antimicrobials were 272 
the most commonly administered drugs given before referral in this study, in over 80% of 273 
cats. Furthermore, nearly one-third of all cats had received drugs from multiple 274 
antimicrobial classes by the time of referral. The prevalence of bacterial infections as a cause 275 
of pyrexia in first opinion veterinary practice may be sufficiently high to warrant such 276 
treatment, although no evidence exists to support this. Witholding antimicrobials in stable 277 
patients where fever is acute and mild is recommended in human medicine12. Of note, 278 
despite infections being regarded as (and shown to be in this study) the most common cause 279 
of feline pyrexia, almost one-quarter of cats had received corticosteroids before referral.  280 
A wide range of diagnostic investigations were employed to discern the cause of 281 
pyrexia. Complete blood count and serum biochemistry were performed in all cases but the 282 
most common abnormalities found (neutrophilia, increased ALT, anaemia and 283 
hypoalbuminaemia) were non-specific. Abdominal ultrasonography was the most 284 
commonly performed diagnostic procedure which ‘enabled’ or ‘assisted’ with a diagnosis 285 
in over half of the cats in which it was employed. Thoracic imaging (radiography and/or 286 
CT) was performed in over half of cats and appeared to be less useful than abdominal 287 
ultrasonography. Echocardiography was performed in approximately one-third of cats but 288 
only assisted with diagnosis in one cat (diagnosed with myocarditis); indeed it was 289 
  
seemingly performed in the majority of cases to assess for concurrent cardiac disease due to 290 
the detection of a heart murmur or gallop sounds, as well as to assess for endocarditis. Our 291 
data suggests that diagnostic imaging selection in pyrexic cats should depend on localising 292 
signs (eg, MRI of the brain ‘assisted’ or ‘enabled’ a diagnosis in all cases presented with 293 
neurological signs) rather than seeking abnormalities without appropriate localisation. 294 
Fluid (pleural or peritoneal) analysis was a highly useful diagnostic test when 295 
performed, likely due to its importance in aiding FIP diagnosis. Cytology and 296 
histopathology were widely employed and were very useful diagnostic procedures, in 297 
agreement with canine studies6-8. Bacterial culture (eg, of fluid, tissue) ‘enabled’ or ‘assisted’ 298 
with a diagnosis in approximately one-third of cases in which it was performed, although 299 
false negative results may have occurred due to previous antimicrobial therapy or difficulty 300 
in culturing certain organisms (e.g. Mycoplasma spp.). Interestingly, blood culture was 301 
performed in only one cat and even though this test is often recommended when 302 
investigating feline pyrexia3, 11 it does not appear to be a principal test required for diagnosis. 303 
Feline pancreatic lipase immunoreactivity was performed in over one-quarter of cats, likely 304 
due to its widespread availability as a bench-side test and due to the non-specific clinical 305 
signs of feline pancreatitis (anorexia, lethargy). Its usefulness in obtaining a diagnosis was 306 
fairly low, however, perhaps due to pancreatitis being an uncommon cause of pyrexia, 307 
and/or due to the test’s limitations in diagnosing chronic or mild forms of the condition13.  308 
The study’s population comprised referral cases and therefore likely contained cases 309 
where fever did not spontaneously resolve or respond to empirical treatment, where 310 
localising signs were absent, where simple diagnostic tests failed to identify a cause, or 311 
  
alternatively where a diagnosis was known but intensive management was required. 312 
Ultimately many patients were found to have relatively common conditions (e.g, 313 
pancreatitis, lymphoma, cellulitis) and merely had an unusual or early manifestation of 314 
these diseases that hindered diagnosis prior to referral.  315 
Limitations of this study are largely due to its retrospective nature. Future studies 316 
should focus on a prospective cohort of cats being referred with pyrexia. A larger number 317 
of cases would also enable statistical tests to be performed to further investigate features of 318 
the different disease categories and the diagnostic investigations performed. Appropriate 319 
cases may have been missed due to the search methods employed (e.g, misspelling of 320 
pyrexia) and incomplete records meant that some cases had to be excluded. Interpretation 321 
of records was required in some instances to determine the final diagnosis and disease 322 
category classification. Follow-up data were limited in that only survival to discharge was 323 
known in the majority of cases. Finally, despite the endeavour to exclude hyperthermic cats, 324 
it is still possible that some cases (particularly cats with respiratory impairment) may have 325 
been hyperthermic. Furthermore, a few conditions diagnosed in this study have not been 326 
previously associated with pyrexia (e.g, renal pseudocysts, uroliths, gastrointestinal foriegn 327 
bodies); while it is feasible pyrexia may occur in these conditions due to inflammation 328 
and/or associated infection, hyperthermia cannot be fully excluded. Rectal temperature in 329 
healthy cats can reach 39.3°C in the veterinary consultation room due to stress14. The 330 
inclusion criteria of two or more documented episodes of increased rectal temperature was 331 
used in an attempt to exclude cases with stress hyperthermia.  332 
  333 
  
Conclusions 334 
This is the first descriptive study investigating cases of feline pyrexia. A diligent 335 
search for an infectious cause, particularly FIP, remains a priority in the investigation of cats 336 
with pyrexia. In contrast to dogs, immune-mediated disease is a rare cause for feline 337 
pyrexia. Abdominal ultrasonography and cytology are likely to be useful and readily 338 
available diagnostic procedures. The administration of more than one antimicrobial class 339 
was common in this population.  340 
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Table 1. Antimicrobials administered before referral in a population of 106 cats with 355 
pyrexia 356 
 357 
One antimicrobial administered (n=54) 
AC 35 
Cefovecin 9 
Fluoroquinolone 4 
Clindamycin 4 
Two antimicrobials administered (n=28) 
AC / fluoroquinolone 12 
AC / metronidazole 6 
AC / cefovecin 3 
AC / doxycycline 3 
AC / clindamycin 1 
Fluoroquinolone / cefovecin 1 
Fluoroquinolone / TMPS 1 
Fluoroquinolone / clindamycin 1 
Three or more antimicrobials administered (n=5) 
AC / cefovecin / metronidazole 2 
AC / cefovecin / clindamycin 2 
AC / cefovecin / doxycycline / 
fluoroquinolone 
1 
 358 
AC = amoxicillin-clavulanic acid; TMPS = trimethoprim sulfonamide 359 
Numbers (n) indicate number of cats  360 
  
 361 
Table 2. Utility of diagnostic tests/investigations performed in 106 cats with pyrexia 362 
Test 
Number of cats in which 
test was performed 
(percentage) 
Number of cats 
in which test 
‘Enabled a 
diagnosis’ 
(percentage) 
Number of cats 
in which test 
‘Assisted a 
diagnosis’ 
(percentage) 
Urinalysis 46 (43.4%) 0 2 (4.3%) 
Urine culture 31 (29.2%) 3 (9.7%) 0 
FeLV/FIV testing 74 (69.8%) 
FIV positive = 3 
(4.0%) 
0 
Feline PLI 28 (26.4%) 3 (10.7%)  0 
Abdominal 
ultrasonography 
74 (69.8%) 11 (14.9%) 28 (37.8%) 
Abdominal CT 9 (8.5%) 0 1 (11.1%) 
Thoracic radiography 39 (36.8%) 0 7 (18.9%) 
Thoracic CT 26 (24.5%) 1 (3.8%) 6 (23.1%) 
Echocardiography 33 (31.1%) 0 
0  
(concurrent 
cardiomyopathy  
= 3) 
MRI 7 (6.6%) 1 (14.3%) 6 (85.7%) 
Other imaging (e.g, 
CT/radiography of 
head, joints) 
7 (6.6%) 1 (14.3%) 6 (85.7%) 
Endoscopy 
Bronchoscopy 6 (5.7%)  
GI endoscopy 3 (2.8%) 
Rhinoscopy 1 (0.9%) 
1 (16.7%) 3 (30%) 
Bacterial culture  
(non-urine e.g, fluid, 
tissue) 
31 (29.2%)  5 (16.1%) 5 (16.1%) 
Cytology 43 (40.6%)  16 (25.4%) 12 (27.9%) 
Body cavity fluid 
analysis 
30 (28.3%) 5 (16.6%) 19 (63.3%) 
Histopathology 26 (24.5%) 13 (50.0%) 7 (26.9%) 
Faecal tests  
(culture, parasitology)  
8 (7.5%)  0 3 (37.5%) 
  
Test 
Number of cats in which 
test was performed 
(percentage) 
Number of cats 
in which test 
‘Enabled a 
diagnosis’ 
(percentage) 
Number of cats 
in which test 
‘Assisted a 
diagnosis’ 
(percentage) 
PCR  
(blood, tissue, saliva) 
FCoV 15 (14.2%) 
Haemoplasma 8 (7.5%) 
Mycoplasma felis 5 
(4.7%) 
FCV 5 (4.7%) 
FHV 4 (3.8%) 
Toxoplasma gondii 4 
(3.8%) 
Bordetella bronchiseptica 
4 (3.8%) 
Tritrochomonas foetus 1 
(0.9%) 
Mycobacteria species 1 
(0.9%) 
6 (12.8%) 13 (27.7%) 
Serology  
T. gondii 22 (20.8%) 
FCoV 19 (18.8%) 
2 (4.9%) 17 (41.4%) 
Other tests performed 
but not further 
described 
Alpha-1 glycoprotein, serum troponins, serum electrophoresis, bile 
acids, thyroxine, coagulation testing, serum cobalamin/folate, 
serum ammonia, electrocardiogram, gamma interferon testing, 
Coombs’ testing, Ziehl Neelsen staining 
 363 
FeLV = Feline leukemia virus, FIV = Feline immunodeficiency virus, PLI = pancreatic lipase 364 
immunoreactivity, GI = gastrointestinal, FCoV = Feline coronavirus, FCV = Feline calicivirus, 365 
FHV = Feline herpesvirus PCR = polymerase chain reaction 366 
  367 
  
Table 3. Most common complete blood count and serum biochemistry abnormalities 368 
detected in 104 cats with pyrexia 369 
 370 
Laboratory parameter 
Number of 
cases 
Neutrophil abnormalities  50 
    Mild neutrophilia 13 
    Moderate neutrophilia 14 
    Severe neutrophilia 9 
    Band neutrophilia (normal overall neutrophil count) 7 
    Neutropenia 7 
Anaemia 39 
    Mild 18 
    Moderate 17 
    Severe 4 
Increased alanine transaminase  (ALT) 48 
    Mild 37 
    Moderate 9 
    Severe 2 
Hypoalbuminaemia 32 
   Mild 14 
   Moderate 14 
   Severe 4 
 371 
 372 
Neutrophilia: mild (12 to <20 x 109/l), moderate (20 to <30 x 109/l), severe (≥30 x 109/l). 373 
Neutropenia: <4 x 109/L. Anaemia: mild (PCV 20 to ≤24%), moderate (15 to <20%), severe 374 
(<15%). ALT: mild (<2 times upper reference range), moderate (≥2 to 3 times), severe (>3 375 
times). Hypoalbuminaemia: mild (20 to <24 g/l), moderate (16 to <20 g/l), severe (<6 g/l). 376 
  377 
  
 378 
Table 4. Final diagnosis and disease category classification for 106 cats with pyrexia 379 
Disease group Diagnosis Number of cats 
Infectious FIP 
Cellulitis/otitis (media) 
Pyothorax  
Pyelonephritis/UTI 
Lower airway inflammation with M.felis 
Neutrophilic cholangiohepatitis 
Campylobacter enteritis 
Bronchopneumonia  
Brain empyema 
Hepatic abscess  
TOTAL 
22 
4 
3 
3 
2 
2 
2 
1 
1 
1 
41 (38.7%) 
Inflammatory  Pancreatitis 
Sterile peritonitis 
Sterile lymphadenitis/panniculitis/cellulitis 
Inflammatory lower airway disease 
Lymphocytic cholangiohepatitis  
Inflammatory CNS disease 
Myocarditis  
TOTAL 
5 
3 
3 
3 
2 
2 
1 
19 (17.9%) 
Neoplasia Lymphoma  
Pulmonary carcinoma 
Leukaemia (not characterised) 
Pulmonary metastases, primary neoplasm not 
identified  
Gastrointestinal adenocarcinoma 
TOTAL 
6 
3 
2 
1 
 
1 
13 (12.3%) 
Immune-
mediated  
Immune-mediated haemolytic anaemia 
Immune-mediated polyarthritis 
TOTAL 
3 
3 
6 (5.7%) 
Miscellaneous Intestinal obstruction (foreign body)  
Bone marrow disorder (not characterised) 
Ureterolithiasis/urolithiasis  
Intussusception  
Peri-renal pseudocysts 
Trauma 
Hippocampal necrosis 
TOTAL 
3 
2 
2 
1 
1 
1 
1 
11 (10.4%) 
No diagnosis 
(PUO) 
TOTAL 16 (15.0%) 
 380 
 381 
FIP = Feline infectious peritonitis, UTI = urinary tract infection, CNS = central nervous 382 
system, PUO = pyrexia of unknown origin 383 
  
Table 5. Median age of 106 cats with pyrexia, as classified by disease category  
 
 
PUO = pyrexia of unknown origin  
Disease groups All cats Infectious  Inflammatory  Neoplasia Miscellaneous 
Immune-
mediated  
No diagnosis 
(PUO) 
Median (range) age 
(years) 
4.0 (0.2 – 15) 2.5 (0.1-15.0) 5.0 (0.6-12.0) 
8.0  
(1.0-14.0) 
3.0 (0.6-8.0) 8.5 (1.0-13.0) 3.0 (0.1-14.0) 
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